Activation of the Serine/Theronine Protein Kinase Akt in Enteropancreatic Neuroendocrine Tumors

被引:0
|
作者
Ghayouri, Masoumeh [1 ]
Boulware, David [2 ]
Nasir, Aejaz [3 ,4 ]
Strosberg, Jonathan [4 ]
Kvols, Larry [4 ]
Coppola, Domenico [4 ,5 ]
机构
[1] Univ S Florida, Dept Pathol, Coll Med, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Expt Therapeut, Tampa, FL USA
关键词
p-Akt; immunohistochemistry; neuroendocrine tumors; ENDOTHELIAL GROWTH-FACTOR; MEDULLARY-THYROID CANCER; CELL GROWTH; GASTROINTESTINAL TUMORS; SIGNALING PATHWAY; DIGESTIVE-SYSTEM; ENDOCRINE TUMORS; FACTOR RECEPTOR; FACTOR-ALPHA; EXPRESSION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Akt is a regulator of cell proliferation, tumorigenesis and apoptosis. This study evaluated the incidence of Akt activation in a subset of neuroendocrine tumors (NETs) and its correlation to clinical pathological parameters. Materials and Methods: A subset of 46 samples from patients with enteropancreatic NETs (26 male and 20 female) were selected for evaluation. The tissue slides were stained with a mouse monoclonal antiphospho-Akt antibody using the avidin-biotin-complex method. Results: The tumors were from the small (n=18) and large bowel (n=9) and from the pancreas (n=16). Activation of Akt was detected in 61% (28/46) of cases. No statistical correlation was found between the p-Akt score and tumor grade (p=0.72), tumor size (p=0.72) and the presence of metastases (p=0.52). Conclusion: This study shows activation of Akt in a subset of enteropancreatic NET for the first time. This finding suggests a role of p-Akt in NET carcinogenesis.
引用
收藏
页码:5063 / 5067
页数:5
相关论文
共 50 条
  • [41] Circulating Biomarkers in Neuroendocrine Tumors of the Enteropancreatic Tract: Application to Diagnosis, Monitoring Disease, and as Prognostic Indicators
    Ardill, Joy E. S.
    O'Dorisio, Thomas M.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (04) : 777 - +
  • [42] Lipid based inhibitors of the serine/threonine kinase Akt
    Dennis, PA
    ANNALS OF ONCOLOGY, 2005, 16 : 16 - 16
  • [44] Dyrk1A, a Serine/Threonine Kinase, is Involved in ERK and Akt Activation in the Brain of Hyperhomocysteinemic Mice
    Abekhoukh, Sabiha
    Planque, Chris
    Ripoll, Clementine
    Urbaniak, Paulina
    Paul, Jean-Louis
    Delabar, Jean-Maurice
    Janel, Nathalie
    MOLECULAR NEUROBIOLOGY, 2013, 47 (01) : 105 - 116
  • [45] Dyrk1A, a Serine/Threonine Kinase, is Involved in ERK and Akt Activation in the Brain of Hyperhomocysteinemic Mice
    Sabiha Abekhoukh
    Chris Planque
    Clémentine Ripoll
    Paulina Urbaniak
    Jean-Louis Paul
    Jean-Maurice Delabar
    Nathalie Janel
    Molecular Neurobiology, 2013, 47 : 105 - 116
  • [46] NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
    Ozes, ON
    Mayo, LD
    Gustin, JA
    Pfeffer, SR
    Pfeffer, LM
    Donner, DB
    NATURE, 1999, 401 (6748) : 82 - 85
  • [47] Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt
    Kozikowski, AP
    Sun, HY
    Brognard, J
    Dennis, PA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (05) : 1144 - 1145
  • [48] Activation of hedgehog pathway in neuroendocrine tumors
    Dong, Mei
    Sangai, Takafumi
    Zhao, Qiang
    Rashid, Asif
    Meric-Bernstam, Funda
    Yao, James C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Akt as a potential prognostic marker in neuroendocrine tumors: a possibility?
    Hague, Angela
    Robbins, Helen L.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2016, 3 (04) : 281 - 284
  • [50] Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?
    Dumars, Clotilde
    Foubert, Fanny
    Touchefeu, Yann
    Regenet, Nicolas
    Senellart, Helene
    Matysiak-Budnik, Tamara
    Heymann, Marie-Francoise
    ENDOCRINE, 2016, 53 (02) : 395 - 401